H.C. Wainwright initiated coverage on Artiva Biotherapeutics with a new price target
$ARTV
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
H.C. Wainwright initiated coverage of Artiva Biotherapeutics with a rating of Buy and set a new price target of $20.00